Free provider profile
ASHLEY STARNES, FNP
ANNAPOLIS, MO
Find similar providers: Nurse Practitioner, Family in ANNAPOLIS, MO
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
573-598-4213
Fax
573-598-1101
Practice address
202 ALLEN ST, ANNAPOLIS, MO, 63620
- Registry updated
- 2026-11-10
- NPI issued
- 2016-10-03
- RepVector retrieved
- 11/22/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Nurse Practitioner, Family
363LF0000X
PrimaryRegistered Nurse
163W00000X
Nurse Practitioner, Psych/Mental Health
363LP0808X
27 registered practice locations · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like ASHLEY STARNES?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What ASHLEY STARNES prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Buprenorphine-Naloxone
- Ozempic
- Trelegy Ellipta
- Breo Ellipta
- Trulicity
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
3,398
Medicare patients
186
Part D drug cost
$279,840
Brand-name share
15.9%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ozempic (Semaglutide) | 36 | $34,717 |
| Trulicity (Dulaglutide) | 24 | $23,564 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 26 | $20,610 |
| Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl) | 98 | $19,777 |
| Januvia (Sitagliptin Phosphate) | 13 | $13,108 |
| Jardiance (Empagliflozin) | 14 | $10,661 |
| Breo Ellipta (Fluticasone/Vilanterol) | 25 | $9,887 |
| Vascepa (Icosapent Ethyl) | 23 | $9,487 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across MO — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
